Press releases

19.Jan 22

Scandion Oncology announces share trade by a member of the Board of Directors to a closely associated person hereof
Scandion Oncology, today announced that a member of the Board of Directors ha...

18.Jan 22

Data from CORIST-trial to be presented at ASCO Gastrointestinal Cancers Symposium
Data with Scandion Oncology’s lead compound SCO-101 as combination therapy in...

12.Jan 22

Scandion Oncology enhances its external communication
Scandion Oncology, the Cancer Drug Resistance Company, today announced that M...

02.Dec 21

Scandion Oncology announces share purchase by a member of the Board of Directors
Scandion Oncology A/S, the Cancer Drug Resistance Company, today announced th...

01.Dec 21

Scandion Oncology announce minutes of Extraordinary General Meeting
Scandion Oncology A/S, today announced minutes of the Extraordinary General M...

22.Nov 21

Scandion Oncology announces share purchase by Board of Directors and Executive Management
Scandion Oncology A/S, the Cancer Drug Resistance Company, today announced th...

18.Nov 21

Scandion Oncology A/S announces its results for the third quarter of 2021

17.Nov 21

Scandion Oncology announce notice convening an Extraordinary General Meeting
Scandion Oncology A/S, today announced to convene an Extraordinary General M...

15.Nov 21

Invitation to Scandion Oncology A/S webcast and conference call November 18, 2021

12.Nov 21

Scandion Oncology announce cancellation of extraordinary general meeting
Scandion Oncology A/S, today announced that the extraordinary general meeting...

Load more (100)